Literature DB >> 24712458

Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.

Kate S Smigiel1, Shivani Srivastava, J Michael Stolley, Daniel J Campbell.   

Abstract

Regulatory T (Treg) cells play a vital role in the prevention of autoimmunity and the maintenance of self-tolerance, but these cells also have an active role in inhibiting immune responses during viral, bacterial, and parasitic infections. Although excessive Treg activity can lead to immunodeficiency, chronic infection, and cancer, too little Treg activity results in autoimmunity and immunopathology and impairs the quality of pathogen-specific responses. Recent studies have helped define the homeostatic mechanisms that support the diverse pool of peripheral Treg cells under steady-state conditions and delineate how the abundance and function of Treg cells changes during inflammation. These findings are highly relevant for developing effective strategies to manipulate Treg cell activity to promote allograft tolerance and treat autoimmunity, chronic infection, and cancer.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autoimmunity; homeostasis; inflammation; regulatory T cells

Mesh:

Substances:

Year:  2014        PMID: 24712458      PMCID: PMC4083836          DOI: 10.1111/imr.12170

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  191 in total

1.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

2.  The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

Authors:  Aysefa Doganci; Tatjana Eigenbrod; Norbert Krug; George T De Sanctis; Michael Hausding; Veit J Erpenbeck; El-Bdaoui Haddad; Hans A Lehr; Edgar Schmitt; Tobias Bopp; Karl-J Kallen; Udo Herz; Steffen Schmitt; Cornelia Luft; Olaf Hecht; Jens M Hohlfeld; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Stefan Rose-John; Harald Renz; Markus F Neurath; Peter R Galle; Susetta Finotto
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.

Authors:  Justin R Killebrew; Nikole Perdue; Alan Kwan; Angela M Thornton; Ethan M Shevach; Daniel J Campbell
Journal:  J Immunol       Date:  2011-06-20       Impact factor: 5.422

4.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.

Authors:  Wei Tan; Weizhou Zhang; Amy Strasner; Sergei Grivennikov; Jin Q Cheng; Robert M Hoffman; Michael Karin
Journal:  Nature       Date:  2011-02-16       Impact factor: 49.962

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

6.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

7.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

8.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

9.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

10.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  86 in total

1.  Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.

Authors:  Jenna M Sullivan; Barbara Höllbacher; Daniel J Campbell
Journal:  J Immunol       Date:  2018-12-05       Impact factor: 5.422

2.  Enhanced renewal of regulatory T cells in relation to CD4(+) conventional T lymphocytes in the peripheral compartment.

Authors:  Jeane de Souza Nogueira; Fábio Barrozo do Canto; Caroline Fraga Cabral Gomes Nunes; Pedro Henrique Oliveira Vianna; Luciana de Souza Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Immunology       Date:  2015-12-17       Impact factor: 7.397

3.  Oxidative Stress and Metabolism: The NF-Erythroid 2 p45-Related Factor 2:Kelch-like ECH-Associated Protein 1 System and Regulatory T Lymphocytes in Ischemic AKI.

Authors:  Christopher Y Lu; Natalia de Albuquerque Rocha
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

4.  Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Authors:  Mohanraj Sadasivam; Sanjeev Noel; Sul A Lee; Jing Gong; Mohamad E Allaf; Phillip Pierorazio; Hamid Rabb; Abdel Rahim A Hamad
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

5.  Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance.

Authors:  Jane E Klann; Stephanie H Kim; Kelly A Remedios; Zhaoren He; Patrick J Metz; Justine Lopez; Tiffani Tysl; Jocelyn G Olvera; Jailal N Ablack; Joseph M Cantor; Brigid S Boland; Gene Yeo; Ye Zheng; Li-Fan Lu; Jack D Bui; Mark H Ginsberg; Brian G Petrich; John T Chang
Journal:  J Immunol       Date:  2018-04-27       Impact factor: 5.422

6.  STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Authors:  Ludovic Desvignes; Carl Weidinger; Patrick Shaw; Martin Vaeth; Theo Ribierre; Menghan Liu; Tawania Fergus; Lina Kozhaya; Lauren McVoy; Derya Unutmaz; Joel D Ernst; Stefan Feske
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

7.  Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells.

Authors:  Aya Shiokawa; Ryutaro Kotaki; Tomohiro Takano; Haruyo Nakajima-Adachi; Satoshi Hachimura
Journal:  Immunology       Date:  2017-06-01       Impact factor: 7.397

8.  Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool.

Authors:  Jane E Klann; Kelly A Remedios; Stephanie H Kim; Patrick J Metz; Justine Lopez; Lauren A Mack; Ye Zheng; Mark H Ginsberg; Brian G Petrich; John T Chang
Journal:  J Immunol       Date:  2017-05-17       Impact factor: 5.422

9.  Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression.

Authors:  Valerie A Gerriets; Rigel J Kishton; Marc O Johnson; Sivan Cohen; Peter J Siska; Amanda G Nichols; Marc O Warmoes; Aguirre A de Cubas; Nancie J MacIver; Jason W Locasale; Laurence A Turka; Andrew D Wells; Jeffrey C Rathmell
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

10.  A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen.

Authors:  J Michael Stolley; Daniel J Campbell
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.